259 related articles for article (PubMed ID: 11322335)
1. Membrane-bound guanylate cyclase as the receptor of natriuretic peptides. A minireview.
Rambotti MG; Spreca A; Donato R
Ital J Anat Embryol; 1995; 100 Suppl 1():55-62. PubMed ID: 11322335
[TBL] [Abstract][Full Text] [Related]
2. Ultracytochemical localization of particulate guanylate cyclase after stimulation with natriuretic peptides in lamb olfactory mucosa.
Spreca A; Rambotti MG
Histochem J; 1994 Oct; 26(10):778-86. PubMed ID: 7883588
[TBL] [Abstract][Full Text] [Related]
3. Localization of natriuretic peptides and their activation of particulate guanylate cyclase and nitric oxide synthase in the retina.
Blute TA; Lee HK; Huffmaster T; Haverkamp S; Eldred WD
J Comp Neurol; 2000 Sep; 424(4):689-700. PubMed ID: 10931490
[TBL] [Abstract][Full Text] [Related]
4. Ultracytochemical localization of guanylate cyclase after stimulation with natriuretic peptides in frog choroid plexus.
Tei S; Farnesi RM; Santarella B; Secca T; Vagnetti D
J Submicrosc Cytol Pathol; 1998 Jul; 30(3):355-63. PubMed ID: 9723195
[TBL] [Abstract][Full Text] [Related]
5. Catalytic activation of guanylate cyclase/atrial natriuretic factor receptor by combined effects of ANF and GTP gamma S in plasma membranes of Leydig tumor cells: involvement of G-proteins.
Khurana ML; Pandey KN
Arch Biochem Biophys; 1995 Jan; 316(1):392-8. PubMed ID: 7840642
[TBL] [Abstract][Full Text] [Related]
6. Quercetin, a phytoestrogen and dietary flavonoid, activates different membrane-bound guanylate cyclase isoforms in LLC-PK1 and PC12 cells.
Chen ZJ; Vetter M; Chang GD; Liu S; Chang CH
J Pharm Pharmacol; 2003 Mar; 55(3):353-8. PubMed ID: 12724041
[TBL] [Abstract][Full Text] [Related]
7. The receptor attributable to C-type natriuretic peptide-induced differentiation of osteoblasts is switched from type B- to type C-natriuretic peptide receptor with aging.
Kaneki H; Kurokawa M; Ide H
J Cell Biochem; 2008 Feb; 103(3):753-64. PubMed ID: 17562543
[TBL] [Abstract][Full Text] [Related]
8. C-type natriuretic peptide/guanylate cyclase B system in ATDC5 cells, a chondrogenic cell line.
Suda M; Tanaka K; Yasoda A; Komatsu Y; Chusho H; Miura M; Tamura N; Ogawa Y; Nakao K
J Bone Miner Metab; 2002; 20(3):136-41. PubMed ID: 11984695
[TBL] [Abstract][Full Text] [Related]
9. Molecular physiology of natriuretic peptide signalling.
Kuhn M
Basic Res Cardiol; 2004 Mar; 99(2):76-82. PubMed ID: 14963665
[TBL] [Abstract][Full Text] [Related]
10. Structural and biochemical identity of retinal rod outer segment membrane guanylate cyclase.
Margulis A; Goraczniak RM; Duda T; Sharma RK; Sitaramayya A
Biochem Biophys Res Commun; 1993 Jul; 194(2):855-61. PubMed ID: 8102054
[TBL] [Abstract][Full Text] [Related]
11. Apparent B-type natriuretic peptide selectivity in the kidney due to differential processing.
Kishimoto I; Hamra FK; Garbers DL
Can J Physiol Pharmacol; 2001 Aug; 79(8):715-22. PubMed ID: 11558680
[TBL] [Abstract][Full Text] [Related]
12. Non-genomic effects of tamoxifen on the activation of membrane-bound guanylate cyclase GC-A.
Chen ZJ; Vetter M; Chang GD; Liu S; Ding Y; Chang CH
J Pharm Pharmacol; 2003 Nov; 55(11):1539-45. PubMed ID: 14713365
[TBL] [Abstract][Full Text] [Related]
13. Natriuretic peptide system in the human retina.
Rollín R; Mediero A; Roldán-Pallarés M; Fernández-Cruz A; Fernández-Durango R
Mol Vis; 2004 Jan; 10():15-22. PubMed ID: 14737067
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological evidence for the heterogeneity of atrial natriuretic factor-R1 receptor subtype.
Féthière J; De Léan A
Mol Pharmacol; 1991 Dec; 40(6):915-22. PubMed ID: 1684636
[TBL] [Abstract][Full Text] [Related]
15. Functional analysis of natriuretic peptide receptors in the bladder of the toad, Bufo marinus.
Meier SK; Donald JA
Gen Comp Endocrinol; 2002 Feb; 125(2):207-17. PubMed ID: 11884066
[TBL] [Abstract][Full Text] [Related]
16. Natriuretic peptide-induced relaxation of myometrium from the pregnant guinea pig is not mediated by guanylate cyclase activation.
Carvajal JA; Aguan K; Thompson LP; Buhimschi IA; Weiner CP
J Pharmacol Exp Ther; 2001 Apr; 297(1):181-8. PubMed ID: 11259543
[TBL] [Abstract][Full Text] [Related]
17. Cardiac and intestinal natriuretic peptides: insights from genetically modified mice.
Kuhn M
Peptides; 2005 Jun; 26(6):1078-85. PubMed ID: 15911075
[TBL] [Abstract][Full Text] [Related]
18. Negative functional effects of natriuretic peptides are attenuated in hypertrophic cardiac myocytes by reduced particulate guanylyl cyclase activity.
Meyer M; Zhang Q; Khurana K; Scholz PM; Weiss HR
J Cardiovasc Pharmacol; 2007 Feb; 49(2):100-5. PubMed ID: 17312451
[TBL] [Abstract][Full Text] [Related]
19. Diverging vasorelaxing effects of C-type natriuretic peptide in renal resistance arteries and aortas of GC-A-deficient mice.
Steinmetz M; Potthast R; Sabrane K; Kuhn M
Regul Pept; 2004 Jun; 119(1-2):31-7. PubMed ID: 15093694
[TBL] [Abstract][Full Text] [Related]
20. Detection of membrane-bound guanylate cyclase activity in rat C6 glioma cells at different growth states following activation by natriuretic peptides.
Sorci G; Spreca A; Donato R; Rambotti MG
Brain Res; 1995 Jun; 683(1):51-8. PubMed ID: 7552344
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
